Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Exclusive Picks From Street’s Top Biotech Analyst
CNBC
Saturday, November 20, 2010 - 12:15pm
tags:
Human Genome Sciences, Amgen, United Therapeutics
Sanofi Buyout Target Genzyme to Meet U.S. Deadline to Change Manufacturing
Bloomberg
Saturday, November 20, 2010 - 12:14pm
tags:
Sanofi, Genzyme
Molecular Insight Receives Extension of Waiver Agreement With Bond Holders
Yahoo/MarketWire
Saturday, November 20, 2010 - 12:13pm
tags:
Molecular Insight
Regeneron Schedules November 22, 2010 Teleconference and Webcast to Discuss Results of Two Phase 3 Studies with VEGF Trap-Eye in Wet Age-related Macular Degeneration
Yahoo/PR NewsWire
Saturday, November 20, 2010 - 12:12pm
tags:
Regeneron, VEGF Trap-Eye, macular degeneration, age-related macular degeneration
Amgen's Bone Drug Denosumab Cleared to Treat Fractures in Cancer Patients
Bloomberg
Saturday, November 20, 2010 - 12:10pm
tags:
Amgen, denosumab, cancer
Two Obagi shareholders selling off their stakes
Yahoo/AP
Saturday, November 20, 2010 - 12:09pm
tags:
Obagi Medical Products
Exelixis: Up 32% With Room to Run
Motley Fool
Saturday, November 20, 2010 - 12:08pm
tags:
XL184, ovarian cancer, prostate cancer, Exelixis, Bristol-Myers Squibb
FDA orders painkiller Darvon off U.S. market
Marketwatch
Friday, November 19, 2010 - 1:43pm
tags:
Darvon, Darvocet, FDA, painkillers, Xanodyne
MELA Sciences Soars On FDA Approval
Forbes
Friday, November 19, 2010 - 1:41pm
tags:
MELA Sciences, FDA, melanoma, MelaFind
Kendle International: Outlook Improving, Valuation Compelling
Seeking Alpha
Friday, November 19, 2010 - 1:39pm
tags:
Kendle
Pfizer Says Axitinib Trial Met its Primary Endpoint
Bloomberg
Friday, November 19, 2010 - 1:38pm
tags:
Axitinib, Pfizer, clinical trials, cancer
Medicare's 23% Doctor Pay Cuts to Be Delayed as Senate Seeks Longer Fix
Bloomberg
Friday, November 19, 2010 - 11:26am
tags:
physicians, Medicare, healthcare reform
The Orphanization of Drug Development
Minyanville
Friday, November 19, 2010 - 11:22am
tags:
drug development, R&D, orphan drugs
And Now Bayer Is Cutting A Lot Of Jobs
Pharmalot
Friday, November 19, 2010 - 11:21am
tags:
layoffs, Bayer
Johnson & Johnson, Takeda Units Recall Velcade Drug After Particle Reports
Bloomberg
Friday, November 19, 2010 - 11:17am
tags:
JNJ, Takeda, Velcade
Pfizer, Bristol-Myers slip on drug setback
Marketwatch
Friday, November 19, 2010 - 11:17am
tags:
Pfizer, Bristol-Myers Squibb, Apixaban
Amgen's Xgeva Approved
Yahoo/Zacks.com
Friday, November 19, 2010 - 11:16am
tags:
FDA, Amgen, Xgeva
AstraZeneca leaves door open for sale of Swedish unit Astra Tech, which analysts value at $2B
Yahoo/AP
Friday, November 19, 2010 - 11:15am
tags:
AstraZeneca, M&A, Astra Tech, dental implants
Obesity Drug Risks Prompt New Wide-Reaching EU Drug Data Disclosure Rule
Bloomberg
Friday, November 19, 2010 - 11:14am
tags:
obesity, Europe, Acomplia, Sanofi
FDA halts Pfizer blood thinner study due to bleeding
Yahoo/AP
Thursday, November 18, 2010 - 7:02pm
tags:
Pfizer, blood thinners, FDA, Apixaban

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.